the Daily read
Understand the issues
.
| AN ARTICLE A DAY, PICKED BY OUR EDITORS
|
|
| Better healthcare is an absolute good. But whose health concerns have we been solving for? The analysis changes as we think through an equity lens. Indeed, health inequities manifest in a variety of ways: limited access to food, care, or medication; unmet needs, when innovation is misaligned with disease burdens; or underserved communities, when key actors fail to engage groups commensurate with their needs. Addressing the issues has obvious benefits for patients—and the pharmaceutical and life sciences companies that serve them. A new article outlines a framework to approach health equity, recognize its limits, and sharpen decision making. Don’t miss it. |
| — Torea Frey, managing editor, Seattle |
|
|
Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust.
|
|
Did you enjoy this newsletter? Forward it to colleagues and friends so they can subscribe too.
Was this issue forwarded to you? Sign up for it and sample our 40+ other free email subscriptions here.
|
|
|
This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy.
|
|
You received this email because you subscribed to the Daily Read newsletter.
|
|
|
|
Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007
|
|
|
|
